Table 3 Multivariate survival analysis (Cox’ proportional hazards regression model) of clinico-pathologic variables and LCN2 expression in patients with endometrial cancer (n = 255)
From: Lipocalin 2 expression is associated with aggressive features of endometrial cancer
Variables | Categories | HRa | 95% CIb | P-valuec |
|---|---|---|---|---|
LCN2 | Negative | 1.0 | 0.027 | |
Weak/moderate | 1.1 | 0.6-1.9 | ||
Strong | 3.9 | 1.4-10.8 | ||
Histologic type | Endometrioid | 1.0 | NS | |
Non-endometrioid | 1.7 | 0.9-3.2 | ||
Histologic grade | Grade 1 and 2 | 1.0 | <0.001 | |
Grade 3 | 2.8 | 1.6-4.9 | ||
FIGO stage | I/II | 1.0 | <0.001 | |
III/IV | 8.0 | 4.8-13.6 |